[go: up one dir, main page]

WO2012173382A3 - Composition à usage externe pour l'épiderme, contenant du tanshinone ii a en tant que principe actif - Google Patents

Composition à usage externe pour l'épiderme, contenant du tanshinone ii a en tant que principe actif Download PDF

Info

Publication number
WO2012173382A3
WO2012173382A3 PCT/KR2012/004644 KR2012004644W WO2012173382A3 WO 2012173382 A3 WO2012173382 A3 WO 2012173382A3 KR 2012004644 W KR2012004644 W KR 2012004644W WO 2012173382 A3 WO2012173382 A3 WO 2012173382A3
Authority
WO
WIPO (PCT)
Prior art keywords
active ingredient
skin
external use
use containing
skin composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2012/004644
Other languages
English (en)
Korean (ko)
Other versions
WO2012173382A2 (fr
Inventor
이옥찬
염명훈
조가영
이진영
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amorepacific Corp
Original Assignee
Amorepacific Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amorepacific Corp filed Critical Amorepacific Corp
Publication of WO2012173382A2 publication Critical patent/WO2012173382A2/fr
Publication of WO2012173382A3 publication Critical patent/WO2012173382A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
    • A61Q1/06—Lipsticks

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cosmetics (AREA)

Abstract

La présente invention concerne une composition à usage externe pour l'épiderme, contenant en tant que principe actif du tanshinone II A, un isomère, un précurseur, un sel, un hydrate ou un solvate de ce dernier. La composition selon la présente invention a pour effets de blanchir, d'hydrater et d'améliorer la teinte et la transparence de la peau.
PCT/KR2012/004644 2011-06-17 2012-06-13 Composition à usage externe pour l'épiderme, contenant du tanshinone ii a en tant que principe actif Ceased WO2012173382A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20110058902A KR101509848B1 (ko) 2011-06-17 2011-06-17 탄시논ⅱａ를 유효성분으로 함유하는 피부 외용제 조성물
KR10-2011-0058902 2011-06-17

Publications (2)

Publication Number Publication Date
WO2012173382A2 WO2012173382A2 (fr) 2012-12-20
WO2012173382A3 true WO2012173382A3 (fr) 2013-03-14

Family

ID=47357592

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/004644 Ceased WO2012173382A2 (fr) 2011-06-17 2012-06-13 Composition à usage externe pour l'épiderme, contenant du tanshinone ii a en tant que principe actif

Country Status (2)

Country Link
KR (1) KR101509848B1 (fr)
WO (1) WO2012173382A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106420387B (zh) * 2016-11-03 2019-08-13 浙江大学 一种中药化合物靶向脂质纳米球组合物及其制备方法
KR102611023B1 (ko) * 2018-11-21 2023-12-08 (주)아모레퍼시픽 탈수소 아비에틱산을 포함하는 피부 장벽 강화용 또는 보습용 피부 외용제 조성물
CN110787152B (zh) * 2019-12-10 2023-11-21 宁夏医科大学 一种促进皮肤吸收能力低药物的透皮凝胶贴剂及制备方法
JP7395637B2 (ja) * 2022-03-28 2023-12-11 株式会社ナリス化粧品 ヒアルロニダーゼ阻害剤
CN117487154A (zh) * 2023-10-31 2024-02-02 暨南大学 一种丹参酮衍生物及其制备方法和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100853377B1 (ko) * 2006-10-31 2008-08-21 (주)아모레퍼시픽 피부세포의 프로테아솜 활성을 촉진시키는 항노화 조성물
WO2009050451A1 (fr) * 2007-10-15 2009-04-23 Botanic Century (Beijing) Co. Ltd Composition antibactérienne contenant des extraits de salvia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010106001A (ja) 2008-10-31 2010-05-13 Theravalues Corp Ｐｐａｒ活性化剤

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100853377B1 (ko) * 2006-10-31 2008-08-21 (주)아모레퍼시픽 피부세포의 프로테아솜 활성을 촉진시키는 항노화 조성물
WO2009050451A1 (fr) * 2007-10-15 2009-04-23 Botanic Century (Beijing) Co. Ltd Composition antibactérienne contenant des extraits de salvia

Also Published As

Publication number Publication date
KR20120139222A (ko) 2012-12-27
WO2012173382A2 (fr) 2012-12-20
KR101509848B1 (ko) 2015-04-08

Similar Documents

Publication Publication Date Title
MX367618B (es) Compuestos de benzofuranilo y benzoxazolilo sustituídos, y sus usos.
HK1215579A1 (zh) 被取代的2，3-二氫苯並呋喃基化合物和其用途
WO2009118107A3 (fr) Composition d'un produit de soins cutanés
WO2012068234A3 (fr) Composés antiviraux
IN2015DN01119A (fr)
PH12015501609A1 (en) Phenicol antibacterials
WO2013061004A8 (fr) Nouveaux composés di-substitués de la diamino-3,4-cyclobutène-3-dione-1,2 utiles dans le traitement de pathologies médiées par des chimiokines
CA2878796C (fr) Derives de pyridinone comme inhibiteurs de la transglutaminase tissulaire
MY168212A (en) A new therapeutical composition containing apomorphine as active ingredient
EP3354254A4 (fr) Composition pour le blanchiment de la peau contenant du bêta-mangostin comme principe actif
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
PH12018500377A1 (en) Novel annelated benzamides
WO2012076109A3 (fr) 2-pyrones
PH12014501140B1 (en) Protective agent for keratoconjunctiva or suppressive agent for keratoconjunctival disorder
ZA201500362B (en) Novel compound having ability to inhibit 11b-hsd1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient
WO2012173382A3 (fr) Composition à usage externe pour l'épiderme, contenant du tanshinone ii a en tant que principe actif
MX366829B (es) Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas.
UA109460C2 (uk) N-гетарилметилпіразолілкарбоксаміди
WO2012173383A3 (fr) Composition à usage externe pour l'épiderme, contenant en tant que principe actif du cryptotanshinone
WO2014056851A3 (fr) Formulation (i) d'arôme et de parfum
WO2012116992A3 (fr) Utilisation orale
WO2012065028A3 (fr) Tétracyclines substituées
WO2012082942A3 (fr) Analogues de neuropeptides, compositions et procédés pour le traitement de la douleur
WO2016014864A8 (fr) Hydroxy-(r)-2,2'-bisméthylnaltrexones et leurs utilisations
EA201500446A1 (ru) Фармацевтическая композиция для снижения уровня n-оксида триметиламина

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12800481

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 07/04/2014)

122 Ep: pct application non-entry in european phase

Ref document number: 12800481

Country of ref document: EP

Kind code of ref document: A2